Evan M. Cale - Concepedia

Author

Evan M. Cale

National Institute of Allergy and Infectious Diseases ORCID

Also Known As

Evan Cale, Evan M Cale, Evan M. Cale, Evan Mitchel Cale, Moody, M. Anthony

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases National Institutes of Health Duke University Frederick National Laboratory for Cancer Research Beth Israel Deaconess Medical Center

About

Evan M. Cale is an author at National Institute of Allergy and Infectious Diseases specializing in immunology, medicine, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	701
2	Immunology	10	10	701
3	Cell Biology	3	3	217
4	Natural Sciences	1	1	33
5	Molecular Biology	1	1	33

Evan M. Cale

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody Rui Kong, Kai Xu, Tongqing Zhou, Science	2016	369
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency Nicole A. Doria‐Rose, Jinal N. Bhiman, Ryan S. Roark, Journal of Virology	2015	255
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants Lingshu Wang, Tongqing Zhou, Yi Zhang, Science	2021	212
Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual Shelly J. Krebs, Young Do Kwon, Chaim A. Schramm, Immunity Primary ImmunodeficiencyHuman RetrovirusImmunologyAntiviral ResponseVirology	2019	115
Direct Binding of Hepatitis C Virus Core to gC1qR on CD4<sup>+</sup>and CD8<sup>+</sup>T Cells Leads to Impaired Activation of Lck and Akt Zhi Q. Yao, Audrey Eisen-Vandervelde, Stephen N. Waggoner, Journal of Virology Adaptive Immune SystemImmune RegulationImmunologyImmunodominanceImmunologic Mechanism	2004	106
Hepatitis C Virus Core Selectively Suppresses Interleukin-12 Synthesis in Human Macrophages by Interfering with AP-1 Activation Audrey Eisen-Vandervelde, Stephen N. Waggoner, Zhi Q. Yao, Journal of Biological Chemistry Hepatitis C VirusImmunologyHcv CoreImmunologic MechanismImmunotherapy	2004	100
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide S. Munir Alam, Baptiste Aussedat, Yusuf Vohra, Science Translational Medicine	2017	98
Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial Trevor A. Crowell, Donn Colby, Suteeraporn Pinyakorn, The Lancet HIV Treatment And PreventionImmunotherapyHuman RetrovirusImmunologyAntiviral Therapy	2019	98
Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop Evan M. Cale, Jason Gorman, Nathan A. Radakovich, Immunity Virus StructureProtruding LoopHuman RetrovirusImmunologyAntiviral Response	2017	87
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial Joseph P. Casazza, Evan M. Cale, Sandeep Narpala, Nature Medicine VaccinationNeutralizing AntibodyHuman RetrovirusImmunologyAntiviral Therapy	2022	82

Page 1